Oncopeptides
ONCO | ST
Overview
Corporate Details
- ISIN(s):
- SE0009414576 (+4 more)
- LEI:
- 549300J9WWQ5CBYQ1M77
- Country:
- Sweden
- Address:
- Luntmakargatan 46, 111 37 Stockholm
- Website:
- https://www.oncopeptides.com/en
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Oncopeptides is a global biotech company focused on the development of targeted therapies for difficult-to-treat hematological diseases. The company is science driven and is committed to bringing innovation to patients with an unmet need and improving patient quality of life. Oncopeptides uses its proprietary Peptide Drug Candidate platform, PDC, to develop compounds that rapidly and selectively deliver cytotoxic agents into cancer cells. The headquarters is in Stockholm, Sweden, and a modern pre-clinical drug development facility in Solna, outside Stockholm, Sweden.
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-05-22 14:00 |
Declaration of Voting Results & Voting Rights Announcements
Kommuniké från årsstämma i Oncopeptides AB (publ)
|
Swedish | 72.0 KB | |
| 2025-05-22 14:00 |
Declaration of Voting Results & Voting Rights Announcements
Bulletin from the Annual General Meeting in Oncopeptides AB (publ)
|
English | 72.2 KB | |
| 2025-05-15 08:00 |
Quarterly Report
|
Swedish | 517.8 KB | |
| 2025-05-15 08:00 |
Quarterly Report
|
English | 486.8 KB | |
| 2025-04-28 15:30 |
Annual Report
|
Swedish | 6.6 MB | |
| 2025-04-22 12:14 |
Inside Information Statement
|
English | 8.7 KB | |
| 2025-03-03 15:26 |
Declaration of Voting Results & Voting Rights Announcements
|
Swedish | 7.8 KB | |
| 2025-02-28 17:50 |
Declaration of Voting Results & Voting Rights Announcements
Antal aktier och röster i Oncopeptides
|
Swedish | 69.4 KB | |
| 2025-02-28 17:50 |
Declaration of Voting Results & Voting Rights Announcements
Number of shares and votes in Oncopeptides
|
English | 68.8 KB | |
| 2025-02-28 07:00 |
Transaction in Own Shares
Correction: Issue and re-purchase of class C shares for shareholder program
|
English | 74.4 KB | |
| 2025-02-28 07:00 |
Transaction in Own Shares
Rättelse: Emission och återköp av C-aktier för aktieägarprogram
|
Swedish | 76.0 KB | |
| 2025-02-27 15:00 |
Transaction in Own Shares
Issue and re-purchase of class C shares for shareholder program
|
English | 69.0 KB | |
| 2025-02-27 15:00 |
Transaction in Own Shares
Emission och återköp av C-aktier för aktieägarprogram
|
Swedish | 70.0 KB | |
| 2025-02-27 08:00 |
Earnings Release
|
Swedish | 585.3 KB | |
| 2025-02-27 08:00 |
Annual Report
|
English | 647.2 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-04-15 | David Augustsson | Other | Buy | 1,250 | 6,350.00 SEK |
| 2024-04-15 | David Augustsson | Other | Buy | 1,250 | 6,312.50 SEK |
| 2024-04-15 | David Augustsson | Other | Buy | 438 | 2,225.04 SEK |
| 2024-04-15 | David Augustsson | Other | Buy | 60 | 303.60 SEK |
| 2024-04-15 | David Augustsson | Other | Buy | 2 | 10.02 SEK |
| 2023-09-08 | David Augustsson | Other | Buy | 2,296 | 17,706.75 SEK |
| 2023-08-10 | David Augustsson | Other | Buy | 1,704 | 14,995.20 SEK |
| 2023-05-04 | Nicolaas Bakker | Other | Buy | 5,000 | 42,380.00 SEK |
| 2022-10-10 | Nicolaas Bakker | Other | Buy | 15,000 | 164,400.00 SEK |
| 2022-08-30 | Per Wold-Olsen | Other | Buy | 2,050 | 55,350.00 SEK |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
AB Science | France | AB | |
|
Acticor Biotech | France | ALACT | |
|
Active Biotech | Sweden | ACTI | |
|
AcuCort AB | Sweden | ACUC |